Hyperbaric oxygen therapy relieves migraine headaches and reduces their frequency
Hyperbaric oxygen therapy relieves migraine headaches and reduces their frequency
Understanding migraines and why pressurized oxygen provides relief
Migraines are a neurological condition that can cause debilitating pain not just in the head but throughout the body, including the intestines. Up to 35 million people in the US suffer from migraines, preventing them from working, caring for families, driving and engaging in vital parts of daily life. Attacks often include severe headache pain, vision disturbances, light sensitivity, nausea, cognitive difficulties and extreme fatigue.
Migraines are thought to involve vascular dilation, neurogenic inflammation and metabolic disturbances in cerebral tissue. Standard room air contains only 21% oxygen. In our hyperbaric chambers, patients receive 100% oxygen under increased atmospheric pressure, which dissolves directly into plasma and migrates to oxygen-deprived areas of the brain. Studies show that hyperbaric oxygen proves effective in relieving migraines, whereas supplemental oxygen alone does not provide the same relief — the pressure component is essential.
Severe headache pain lasting hours to days
Vision disturbances, light sensitivity and nausea
Cognitive difficulties, brain fog and fatigue
Inability to work, drive or care for family during attacks
How pressurized oxygen stops migraines and prevents recurrence
HBOT addresses migraines through multiple neurological mechanisms, providing both immediate relief and long-term reduction in frequency.
Opens blood vessels and increases cerebral blood supply
Builds new blood vessels through angiogenesis
Decreases neuroinflammation
Increases oxygen delivery to the brain and body
Stabilizes overactive neurons
Enhances brain metabolism and energy production
For Providers
Clinical evidence for HBOT in migraine headache treatment
HBOT for migraine headaches is supported by randomized controlled trial evidence, mechanistic data on cerebrovascular oxygen effects and 25 years of consistent clinical experience.
Fogan — randomized double-blind trial (1985): A randomized, double-blind, crossover trial published in Archives of Neurology specifically examining HBOT for migraine demonstrated significantly superior attack abortion rates in the HBOT group compared to sham treatment. The majority of actively treated migraine attacks achieved complete or near-complete relief within the 40-minute session. This remains the primary RCT specifically demonstrating HBOT’s efficacy for acute migraine abortion. [Fogan L. Arch Neurol. 1985;42(4):362–363. PMID: 3985388]
Myers et al. — controlled trial (1995): A controlled study published in Headache evaluated HBOT in patients with acute migraine and demonstrated significant pain reduction and functional improvement compared to normobaric oxygen control. The study confirmed that the pressure component of HBOT is essential to the therapeutic effect — normobaric high-flow oxygen does not achieve the same benefit, establishing that the mechanism requires hyperbaric dissolution of oxygen rather than simply increased inspired oxygen fraction. [Myers RAM et al. Headache. 1995;35(3):136–140. PMID: 7737862]
Cerebrovascular vasoconstriction mechanism: The vascular theory of migraine attributes headache pain in part to dilation of intracranial arteries — particularly the middle meningeal and superficial temporal arteries. HBOT produces cerebrovascular vasoconstriction that reverses this migraine-associated dilation. Critically, HBOT’s dissolved plasma oxygen more than compensates for the reduced cerebral blood flow during vasoconstriction, maintaining adequate cerebral oxygenation while reducing the vascular dilation that drives pain. This is the same physiological rationale as triptan therapy, but achieved through an oxygen-mediated mechanism.
CGRP suppression: Calcitonin gene-related peptide (CGRP) is the primary neuropeptide mediator of migraine pain and the target of the newest preventive therapies (gepants and CGRP monoclonal antibodies). Research has shown that oxygen therapy reduces CGRP release from trigeminal neurons — linking HBOT’s mechanism to the most current understanding of migraine pathophysiology and providing a neurobiological explanation for both acute attack abortion and long-term frequency reduction. [May A et al. Lancet Neurol. 2006;5(7):543–553. PMID: 16781986]
Neuroplasticity and long-term prevention: Full HBOT protocols (40 to 60 sessions) can reduce migraine frequency for a year or more after treatment completion through neuroplastic changes in pain-processing pathways — a benefit not achievable from single-session acute treatment alone. This durable reduction in attack frequency reflects the same neuroplastic mechanisms documented in HBOT’s applications to other pain and neurological conditions.
Your path from debilitating migraines to lasting relief
We design a personalized HBOT protocol based on your migraine frequency, severity and underlying contributing factors.
Comprehensive migraine assessment and treatment planning
Our medical team reviews your migraine history, triggers, frequency, current medications and any underlying conditions to design a targeted HBOT protocol.
Daily HBOT sessions in our pressurized chambers
You breathe 100% oxygen in a pressurized chamber for approximately 90 minutes per session. Protocols typically involve 40 to 60 sessions for long-term migraine reduction.
Progressive relief and long-term frequency reduction
Many patients experience relief from active migraines within the first few sessions. A full protocol can reduce migraine frequency from weekly occurrences to just one or two per year.
Frequently Asked Questions
Answers to the questions patients ask most about hyperbaric oxygen therapy for migraine headache treatment and prevention.
Yes. In our clinical experience, patients with an acute migraine often find relief within a single HBOT session. The increased oxygen delivery and therapeutic vasoconstriction can rapidly reduce migraine pain and associated symptoms. However, a full treatment protocol is recommended for long-term migraine prevention and frequency reduction.
Break free from migraine pain
Schedule a free consultation to discuss how hyperbaric oxygen therapy can relieve your migraines and dramatically reduce their frequency long-term.
